Top 5 Consumer Service Companies To Own In Right Now

Top 5 Consumer Service Companies To Own In Right Now: Repligen Corporation(RGEN)

Repligen Corporation engages in the manufacture and supply of biologic products used to manufacture biologic drugs. The company offers commercial bioprocessing products based on protein A and IFG-1 growth factors; and pre-packed chromatography columns under the Opus brand, which are used in the production of monoclonal antibodies and other biopharmaceutical products. It also develops SecreFlo, a synthetic human hormone that has completed a Phase III clinical trial and is to be used in combination with magnetic resonance imaging to improve the detection of pancreatic abnormalities in patients with pancreatitis; RG3039, which is in Phase I study for the treatment of patients with spinal muscular atrophy; and RG2833, a class I histone deacetylase inhibitor that is in Phase I study for the treatment of patients with Friedreich?s ataxia. In addition, the company licenses its biologics intellectual property to Bristol-Myers Squibb Company. Repligen Corporation sells its bioproc essing products to life science companies, diagnostics companies, biopharmaceutical companies, and laboratory researchers through its direct sales force, partners, and distributors in certain foreign markets. The company was founded in 1981 and is headquartered in Waltham, Massachusetts.

Advisors' Opinion:

• [By Garrett Cook]

  Healthcare shares fell 0.13 percent on Friday. Top losers in the sector included AcelRx Pharmaceuticals (NASDAQ: ACRX), down 18 percent, and Repligen (NASDAQ: RGEN), off 3.7 percent.

• [By Maxx Chatsko]

  Any company that creates products and relies on other companies to use and distribute them will inevitably forge strong relationships with its customers. It's an important thing to look into when investing, yet easy to overlook. Investors should know whether custome! rs are reliable, which are leaned on the most, and if the company they own is too dependent on any customer (or a select few). Bioprocessing product company Repligen (NASDAQ: RGEN  ) may make consumables that are the lifeline of the biotech industry, but its customer relationships are absolutely critical for smooth operations. Let's look at how the company interacts with the Life Sciences division of General Electric (NYSE: GE  ) , EMD Millipore from Merck (NYSE: MRK  ) , and Sigma-Aldrich (NASDAQ: SIAL  ) -- the three most important customers.

• [By Brian Pacampara]

  Based on the aggregated intelligence of 180,000-plus investors participating in Motley Fool CAPS, the Fool's free investing community, small-cap biotech Repligen (NASDAQ: RGEN  ) has earned a coveted five-star ranking.

• [By CRWE]

  Repligen Corporation (NASDAQ:RGEN) reported that Walter C. Herlihy, Ph.D., President and Chief Executive Officer, will be presenting at the upcoming Stifel Nicolaus Healthcare Conference in Boston.

source from Top Stocks For 2015:http://www.topstocksblog.com/top-5-consumer-service-companies-to-own-in-right-now-2.html